• Thumbnail for Molnupiravir
    Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat...
    46 KB (3,654 words) - 04:29, 18 December 2024
  • Thumbnail for PANORAMIC trial
    were molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid). Results from the trial showed that for higher risk, vaccinated adults molnupiravir does...
    12 KB (1,087 words) - 03:59, 25 November 2024
  • the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along...
    7 KB (510 words) - 13:44, 12 November 2024
  • Thumbnail for COVID-19 drug development
    molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID‑19 pandemic. In September 2023, molnupiravir's vial...
    90 KB (13,197 words) - 04:28, 26 July 2024
  • Thumbnail for AGILE
    include molnupiravir, high-dose nitazoxanide, the monoclonal antibody Vir 7832, intravenous favipiravir, and the combination of molnupiravir plus nirmatrelvir/ritonavir...
    8 KB (878 words) - 05:24, 13 July 2024
  • Thumbnail for Feline infectious peritonitis
    of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline...
    26 KB (2,894 words) - 14:03, 26 December 2024
  • in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19...
    6 KB (547 words) - 14:35, 30 October 2023
  • Thumbnail for COVID-19 pandemic
    adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
    368 KB (32,718 words) - 17:52, 31 December 2024
  • being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
    67 KB (6,361 words) - 23:43, 27 October 2024
  • Thumbnail for COVID-19
    being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
    288 KB (33,190 words) - 07:03, 5 January 2025
  • health and nutrition products including the oral anti covid medication Molnupiravir & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir....
    4 KB (256 words) - 13:52, 6 June 2024
  • Thumbnail for Xavier-Luc Duval
    revealed that private firm MERCK was the sole importer of anti-COVID drugs Molnupiravir and Ronapreve on the island of Mauritius. Kailesh Jagutpal further revealed...
    20 KB (2,165 words) - 11:21, 7 December 2024
  • Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl nitrite Isopentyl...
    26 KB (1,722 words) - 09:50, 2 November 2024
  • HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 Merck & Co. viral RNA polymerase inhibitor Moroxydine Influenza...
    13 KB (513 words) - 00:20, 23 November 2024
  • Thumbnail for 2021 in science
    (~380 patients × 2) clinical trial launched a year ago reports that molnupiravir substantially reduced the risk of hospitalization (7.3% to 14.1%) and...
    299 KB (38,958 words) - 21:53, 29 December 2024
  • Thumbnail for Merck & Co.
    treat millions of people in countries such as Yemen and African nations. Molnupiravir is an antiviral pill to treat COVID-19, developed in partnership with...
    99 KB (9,737 words) - 17:44, 3 January 2025
  • Thumbnail for Pravind Jugnauth
    and maintaining oversight of critical decisions. Molnupiravir Scandal The core issue in the Molnupiravir scandal in Mauritius around December 2021 was the...
    47 KB (4,470 words) - 04:03, 4 January 2025
  • COVID-19 antivirals including paxlovid (nirmatrelvir/ritonavir) and molnupiravir on acute COVID-19 outcomes and long COVID. Including work which evaluated...
    15 KB (1,483 words) - 04:05, 29 November 2024
  • Thumbnail for Viral disease
    (SARS-CoV-2) Coronaviridae droplet contact coronavirus disease 2019 (COVID-19) Molnupiravir, Nirmatrelvir/ritonavir hand washing covering mouth when coughing or...
    36 KB (1,249 words) - 10:35, 10 July 2024
  • Thumbnail for Responses to the COVID-19 pandemic in October 2021
    Government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. The Malaysian Deputy Education Minister...
    25 KB (1,875 words) - 06:47, 20 November 2024
  • Thumbnail for Isko Moreno
    government unit in the country to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
    184 KB (16,120 words) - 13:30, 1 January 2025
  • in the UK: The UK becomes the first country in the world to approve molnupiravir, an oral antiviral pill for COVID-19 that cuts the risk of hospitalisation...
    347 KB (33,564 words) - 12:35, 2 January 2025
  • Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Remdesivir Co-packaged Nirmatrelvir ritonavir...
    180 KB (23,898 words) - 14:59, 19 August 2024
  • Thumbnail for Rick Bright
    additional federal funding to Ridgeback Biotherapeutics to further develop molnupiravir into a treatment for COVID-19. He argued that although the drug had shown...
    31 KB (2,760 words) - 15:59, 28 December 2024
  • Thumbnail for 2020 in science
    speed of classical supercomputers. Scientists report that repurposed Molnupiravir can completely suppress SARS-CoV-2 transmission within 24 hours in ferrets...
    152 KB (27,272 words) - 16:36, 5 October 2024
  • Merck Sharp & Dohme (MSD) to purchase the experimental antiviral pill molnupiravir. If approved by Medsafe, Pharmac will be supplied with 60,000 courses...
    266 KB (17,612 words) - 22:31, 30 December 2024
  • of the replication inhibition of the corona virus by Remdesivir and Molnupiravir 2004 Roche Symposium Award (Leading chemists of the next decade), Basel...
    9 KB (984 words) - 04:00, 24 November 2024
  • marketing authorisation, to Promomed, for Esperavir, a drug based on molnupiravir and developed for the treatment of COVID-19. In April 2022, Ministry...
    17 KB (1,269 words) - 09:55, 6 May 2024
  • government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. Under the Movement Control Order put in...
    221 KB (16,305 words) - 11:13, 31 December 2024
  • Thumbnail for Responses to the COVID-19 pandemic in July 2022
    for vulnerable patients to obtain a range of drugs including paxlovid, molnupiravir, and remdesivir. Timeline of the COVID-19 pandemic in July 2022 Responses...
    3 KB (200 words) - 23:00, 28 August 2024